ACHV
Price
$4.58
Change
-$0.14 (-2.97%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
251.8M
119 days until earnings call
Intraday BUY SELL Signals
ALT
Price
$4.05
Change
-$0.18 (-4.26%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
440.85M
133 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHV vs ALT

Header iconACHV vs ALT Comparison
Open Charts ACHV vs ALTBanner chart's image
Achieve Life Sciences
Price$4.58
Change-$0.14 (-2.97%)
Volume$6.02K
Capitalization251.8M
Altimmune
Price$4.05
Change-$0.18 (-4.26%)
Volume$26.49K
Capitalization440.85M
ACHV vs ALT Comparison Chart in %
ACHV
Daily Signal:
Gain/Loss:
ALT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACHV vs. ALT commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and ALT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ACHV: $4.72 vs. ALT: $4.23)
Brand notoriety: ACHV and ALT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 37% vs. ALT: 86%
Market capitalization -- ACHV: $251.8M vs. ALT: $440.85M
ACHV [@Biotechnology] is valued at $251.8M. ALT’s [@Biotechnology] market capitalization is $440.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileALT’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • ALT’s FA Score: 0 green, 5 red.
According to our system of comparison, ACHV is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 5 TA indicator(s) are bullish while ALT’s TA Score has 6 bullish TA indicator(s).

  • ACHV’s TA Score: 5 bullish, 4 bearish.
  • ALT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ALT is a better buy in the short-term than ACHV.

Price Growth

ACHV (@Biotechnology) experienced а -4.26% price change this week, while ALT (@Biotechnology) price change was +12.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

ACHV is expected to report earnings on Mar 12, 2026.

ALT is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($441M) has a higher market cap than ACHV($252M). ACHV YTD gains are higher at: 34.091 vs. ALT (-41.331). ACHV has higher annual earnings (EBITDA): -49.25M vs. ALT (-88.03M). ALT has more cash in the bank: 183M vs. ACHV (55.4M). ACHV has less debt than ALT: ACHV (9.96M) vs ALT (15.8M). ALT has higher revenues than ACHV: ALT (20K) vs ACHV (0).
ACHVALTACHV / ALT
Capitalization252M441M57%
EBITDA-49.25M-88.03M56%
Gain YTD34.091-41.331-82%
P/E RatioN/AN/A-
Revenue020K-
Total Cash55.4M183M30%
Total Debt9.96M15.8M63%
FUNDAMENTALS RATINGS
ACHV vs ALT: Fundamental Ratings
ACHV
ALT
OUTLOOK RATING
1..100
8674
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
3659
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (53) in the Biotechnology industry is somewhat better than the same rating for ALT (96) in the Miscellaneous Commercial Services industry. This means that ACHV’s stock grew somewhat faster than ALT’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that ACHV’s stock grew similarly to ALT’s over the last 12 months.

ALT's SMR Rating (97) in the Miscellaneous Commercial Services industry is in the same range as ACHV (99) in the Biotechnology industry. This means that ALT’s stock grew similarly to ACHV’s over the last 12 months.

ACHV's Price Growth Rating (36) in the Biotechnology industry is in the same range as ALT (59) in the Miscellaneous Commercial Services industry. This means that ACHV’s stock grew similarly to ALT’s over the last 12 months.

ACHV's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that ACHV’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVALT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signal:
Gain/Loss:
ALT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BFFAF50.49N/A
N/A
BASF SE
FMBM27.10N/A
N/A
F & M Bank Corp.
GNGBY23.31N/A
N/A
Getinge AB
KIERF2.75N/A
N/A
Kier Group Plc
OMMSF0.04N/A
-2.43%
Omineca Mining & Metals Ltd.

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ALT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-1.05%
ALT - ACHV
46%
Loosely correlated
-1.17%
ATNM - ACHV
36%
Loosely correlated
-0.76%
PLRX - ACHV
36%
Loosely correlated
+7.78%
ARTV - ACHV
33%
Loosely correlated
+10.86%
RANI - ACHV
33%
Poorly correlated
+9.28%
More

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with ACHV. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-1.17%
ACHV - ALT
47%
Loosely correlated
-1.05%
INDP - ALT
45%
Loosely correlated
+6.25%
KROS - ALT
39%
Loosely correlated
+3.37%
AMRN - ALT
38%
Loosely correlated
+0.75%
CLDX - ALT
36%
Loosely correlated
-0.49%
More